Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccines, DNA | 1 | 2019 | 5 | 0.710 |
Why?
|
| Dengue Vaccines | 1 | 2019 | 3 | 0.710 |
Why?
|
| Paratyphoid Fever | 1 | 2019 | 3 | 0.690 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2019 | 6 | 0.690 |
Why?
|
| Typhoid Fever | 1 | 2019 | 19 | 0.680 |
Why?
|
| Vaccination | 2 | 2019 | 123 | 0.310 |
Why?
|
| Escherichia coli Infections | 2 | 2018 | 37 | 0.280 |
Why?
|
| Rotavirus Infections | 2 | 2018 | 11 | 0.260 |
Why?
|
| Diarrhea | 2 | 2018 | 56 | 0.210 |
Why?
|
| Injections, Intradermal | 1 | 2019 | 7 | 0.180 |
Why?
|
| Dengue | 1 | 2019 | 4 | 0.180 |
Why?
|
| Dengue Virus | 1 | 2019 | 4 | 0.180 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 17 | 0.180 |
Why?
|
| Electroporation | 1 | 2019 | 14 | 0.180 |
Why?
|
| Interferon-gamma | 1 | 2019 | 51 | 0.180 |
Why?
|
| Injections, Intramuscular | 1 | 2019 | 42 | 0.180 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 55 | 0.170 |
Why?
|
| Vaccines, Conjugate | 1 | 2019 | 15 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 69 | 0.170 |
Why?
|
| Shigella | 1 | 2018 | 7 | 0.170 |
Why?
|
| Rotavirus Vaccines | 1 | 2018 | 7 | 0.170 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2018 | 15 | 0.170 |
Why?
|
| Dysentery, Bacillary | 1 | 2018 | 12 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 92 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 91 | 0.160 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 389 | 0.160 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2014 | 3 | 0.130 |
Why?
|
| Diarrhea, Infantile | 1 | 2014 | 6 | 0.130 |
Why?
|
| Escherichia coli | 1 | 2014 | 82 | 0.120 |
Why?
|
| Child, Preschool | 5 | 2018 | 1167 | 0.120 |
Why?
|
| Rotavirus | 1 | 2010 | 4 | 0.100 |
Why?
|
| Infant | 4 | 2018 | 969 | 0.090 |
Why?
|
| Campylobacter Infections | 1 | 2008 | 6 | 0.090 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2008 | 9 | 0.080 |
Why?
|
| Acinetobacter Infections | 1 | 2008 | 3 | 0.080 |
Why?
|
| Acinetobacter baumannii | 1 | 2008 | 4 | 0.080 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2008 | 11 | 0.080 |
Why?
|
| Pneumonia, Bacterial | 1 | 2008 | 31 | 0.080 |
Why?
|
| Humans | 7 | 2019 | 29093 | 0.080 |
Why?
|
| Egypt | 3 | 2014 | 16 | 0.080 |
Why?
|
| Animals | 1 | 2019 | 7297 | 0.080 |
Why?
|
| Health Personnel | 1 | 2008 | 111 | 0.080 |
Why?
|
| Military Personnel | 1 | 2008 | 85 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2008 | 224 | 0.070 |
Why?
|
| Prevalence | 2 | 2018 | 896 | 0.060 |
Why?
|
| Child | 3 | 2018 | 2219 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2018 | 598 | 0.060 |
Why?
|
| Biostatistics | 1 | 2018 | 8 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 24 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 63 | 0.040 |
Why?
|
| Male | 4 | 2018 | 17807 | 0.040 |
Why?
|
| Female | 4 | 2018 | 18164 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2402 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 440 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 3254 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 795 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 1119 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 29 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 10829 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1362 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1356 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 152 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 629 | 0.030 |
Why?
|
| Adult | 2 | 2018 | 8420 | 0.030 |
Why?
|
| Aged | 2 | 2018 | 9487 | 0.030 |
Why?
|
| Risk Factors | 1 | 2018 | 3531 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3111 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 3717 | 0.020 |
Why?
|
| Hospitals | 1 | 2010 | 89 | 0.020 |
Why?
|
| Gangliosides | 1 | 2008 | 6 | 0.020 |
Why?
|
| Iraq | 1 | 2008 | 1 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 6 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 735 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 15 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 34 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 172 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 285 | 0.020 |
Why?
|
| United States | 1 | 2008 | 3630 | 0.010 |
Why?
|